Astera Labs (NASDAQ:ALAB) Stock Gets Price Target Reduction from Susquehanna

Astera Labs (NASDAQ:ALAB) had its target price lowered by Susquehanna from $310.00 to $258.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

ALAB has been the topic of a number of other reports. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Morgan Stanley increased their price target on Astera Labs from $240.00 to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Needham & Company LLC reduced their price objective on Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research report on Wednesday. Weiss Ratings lowered Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Finally, Jefferies Financial Group upped their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $320.85.

Astera Labs Trading Up 6.3%

ALAB stock traded up $11.24 during midday trading on Wednesday, reaching $190.71. The stock had a trading volume of 6,642,738 shares, compared to its average volume of 4,244,483. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The company’s fifty day simple moving average is $300.46 and its 200 day simple moving average is $255.80. The company has a market cap of $33.09 billion, a price-to-earnings ratio of 75.98 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The business had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 153.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 earnings per share. Sell-side analysts predict that Astera Labs will post 2.71 EPS for the current year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 396,059 shares of company stock worth $123,408,470. Insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Large investors have recently modified their holdings of the business. Diversified Trust Co lifted its position in Astera Labs by 303.8% in the third quarter. Diversified Trust Co now owns 2,100 shares of the company’s stock valued at $748,000 after buying an additional 1,580 shares during the last quarter. Allworth Financial LP raised its stake in shares of Astera Labs by 4.9% in the 3rd quarter. Allworth Financial LP now owns 2,770 shares of the company’s stock valued at $986,000 after acquiring an additional 129 shares during the period. Private Advisory Group LLC purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $971,000. Russell Investments Group Ltd. lifted its holdings in shares of Astera Labs by 9.1% in the 3rd quarter. Russell Investments Group Ltd. now owns 155,991 shares of the company’s stock worth $55,540,000 after acquiring an additional 13,004 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. lifted its holdings in shares of Astera Labs by 26.4% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 58,220 shares of the company’s stock worth $20,725,000 after acquiring an additional 12,144 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
• Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
• Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
• Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
• Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.